MedTrace Logo

A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

NCT03073343 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-05-07

No results posted yet for this study

Summary

Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.

Conditions

  • Non-Alcoholic Fatty Liver Disease
  • Non Insulin Dependent Diabetes
  • ALT

Interventions

DIETARY_SUPPLEMENT

Betaine (trimethyglycine)

Betaine (trimethyglycine) is a food supplement that is approved for sale in the United States without a prescription. In this study, betaine will be provided to patients as a powder that can be mixed with aqueous solutions and consumed orally.

Sponsors & Collaborators

  • Southern California Institute for Research and Education

    lead OTHER

Principal Investigators

  • Timothy R Morgan, MD · VA Long Beach Healthcare System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-12
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03073343 on ClinicalTrials.gov